Can Drosophila melanogaster represent a model system for the detection of reproductive adverse drug reactions?
Authors:
- Sahar SemnaniSSSahar Semnani
- Mahtab JafariMJMahtab Jafari
- 1 August 2009
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 14 (15-16) , 761-766
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Sox100B, a Drosophila Group E Sox-domain Gene, Is Required for Somatic Testis DifferentiationSexual Development, 2009
- From bench to drug: Human seizure modeling using DrosophilaProgress in Neurobiology, 2008
- A role for Drosophila in understanding drug-induced cytotoxicity and teratogenesisCytotechnology, 2008
- TheSf1-related nuclear hormone receptorHr39regulatesDrosophilafemale reproductive tract development and functionDevelopment, 2008
- Pioglitazone: an anti-diabetic compound with anti-aging propertiesBiogerontology, 2007
- Transgenic Rescue of Methotrexate-Induced Teratogenicity in Drosophila melanogasterToxicological Sciences, 2007
- Fgf9 and Wnt4 Act as Antagonistic Signals to Regulate Mammalian Sex DeterminationPLOS Biology, 2006
- Fruit flies for anti-pain drug discoveryLife Sciences, 2005
- A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motifNature, 1990
- Teratogenicity of methotrexate in miceTeratology, 1974